Literature DB >> 19568388

Contemporary treatment of hypertrophic cardiomyopathy.

Ali J Marian1.   

Abstract

Entities:  

Keywords:  Athletic performance; cardiomegaly/genetics; cardiomyopathy, hypertrophic, familial/genetics; cardiomyopathy, hypertrophic/diagnosis/pathology/therapy; catheter ablation/adverse effects; death, sudden, cardiac/epidemiology/etiology/prevention & control; defibrillators, implantable; disease models, animal; genetic predisposition to disease; heart septum; phenotype; risk factors; treatment outcome

Mesh：

Substances：

Year:  2009        PMID： 19568388      PMCID： PMC2696493     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  104 in total

1.  A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

Authors:  A A Geisterfer-Lowrance; S Kass; G Tanigawa; H P Vosberg; W McKenna; C E Seidman; J G Seidman
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

2.  The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy.

Authors:  V V Michels; P P Moll; F A Miller; A J Tajik; J S Chu; D J Driscoll; J C Burnett; R J Rodeheffer; J H Chesebro; H D Tazelaar
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

3.  Syncope in hypertrophic cardiomyopathy: multivariate analysis of prognostic determinants.

Authors:  C A Nienaber; S Hiller; R P Spielmann; M Geiger; K H Kuck
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

4.  Inheritance of hypertrophic cardiomyopathy: a cross sectional and M mode echocardiographic study of 50 families.

Authors:  S C Greaves; A H Roche; J M Neutze; R M Whitlock; A M Veale
Journal:  Br Heart J       Date:  1987-09

5.  Prognosis in hypertrophic cardiomyopathy observed in a large clinic population.

Authors:  M J Kofflard; D J Waldstein; J Vos; F J ten Cate
Journal:  Am J Cardiol       Date:  1993-10-15       Impact factor: 2.778

6.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

Authors:  H Watkins; A Rosenzweig; D S Hwang; T Levi; W McKenna; C E Seidman; J G Seidman
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

7.  Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.

Authors:  Barry J Maron; Joseph J Doerer; Tammy S Haas; David M Tierney; Frederick O Mueller
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

8.  Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

Authors:  R Anan; G Greve; L Thierfelder; H Watkins; W J McKenna; S Solomon; C Vecchio; H Shono; S Nakao; H Tanaka
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

9.  Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study.

Authors:  K Robinson; M P Frenneaux; B Stockins; G Karatasakis; J D Poloniecki; W J McKenna
Journal:  J Am Coll Cardiol       Date:  1990-05       Impact factor: 24.094

Review 10.  Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population.

Authors:  P Spirito; F Chiarella; L Carratino; M Z Berisso; P Bellotti; C Vecchio
Journal:  N Engl J Med       Date:  1989-03-23       Impact factor: 91.245
View more
  18 in total

Review 1.  Hypertrophic cardiomyopathy: from genetics to treatment.

Authors:  Ali J Marian
Journal:  Eur J Clin Invest       Date:  2010-04       Impact factor: 4.686

2.  Passive Microlesion Detection and Mapping for Treatment of Hypertrophic Cardiomyopathy.

Authors:  Yiying I Zhu; Douglas L Miller; Chunyan Dou; Oliver D Kripfgans
Journal:  AIP Conf Proc       Date:  2017-03-01

3.  Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.

Authors:  Frederik Flenner; Birgit Geertz; Silke Reischmann-Düsener; Florian Weinberger; Thomas Eschenhagen; Lucie Carrier; Felix W Friedrich
Journal:  J Physiol       Date:  2017-02-07       Impact factor: 5.182

4.  Characterization of macrolesions induced by myocardial cavitation-enabled therapy.

Authors:  Yiying I Zhu; Douglas L Miller; Chunyan Dou; Oliver D Kripfgans
Journal:  IEEE Trans Biomed Eng       Date:  2014-10-22       Impact factor: 4.538

5.  Optimization of ultrasound parameters of myocardial cavitation microlesions for therapeutic application.

Authors:  Douglas L Miller; Chunyan Dou; Gabe E Owens; Oliver D Kripfgans
Journal:  Ultrasound Med Biol       Date:  2014-03-06       Impact factor: 2.998

6.  Use of Theranostic Strategies in Myocardial Cavitation-Enabled Therapy.

Authors:  Douglas L Miller; Chunyan Dou; Xiaofang Lu; Yiying I Zhu; Mario L Fabiilli; Gabe E Owens; Oliver D Kripfgans
Journal:  Ultrasound Med Biol       Date:  2015-04-15       Impact factor: 2.998

7.  Ultrasonic Cavitation-Enabled Treatment for Therapy of Hypertrophic Cardiomyopathy: Proof of Principle.

Authors:  Douglas L Miller; Xiaofang Lu; Chunyan Dou; Yiying I Zhu; Rachael Fuller; Kristina Fields; Mario L Fabiilli; Gabe E Owens; David Gordon; Oliver D Kripfgans
Journal:  Ultrasound Med Biol       Date:  2018-04-19       Impact factor: 2.998

8.  Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.

Authors:  Marco L Alves; Fernando A L Dias; Robert D Gaffin; Jillian N Simon; Eric M Montminy; Brandon J Biesiadecki; Aaron C Hinken; Chad M Warren; Megan S Utter; Robert T Davis; Sadayappan Sakthivel; Jeffrey Robbins; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  Circ Cardiovasc Genet       Date:  2014-02-28

9.  Molecular modeling, docking and ADMET studies towards development of novel Disopyramide analogs for potential inhibition of human voltage gated sodium channel proteins.

Authors:  Khunza Meraj; Manoj Kumar Mahto; N Blessy Christina; Nidhi Desai; Sajad Shahbazi; Matcha Bhaskar
Journal:  Bioinformation       Date:  2012-11-23

10.  Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy.

Authors:  Sarah N Cilvik; Joy I Wang; Kory J Lavine; Keita Uchida; Angela Castro; Carolyn M Gierasch; Carla J Weinheimer; Stacey L House; Attila Kovacs; Colin G Nichols; David M Ornitz
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.